Skip to main content Accessibility help
×
Home

Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity

  • Jonathan H Soslow (a1), Matthew Hall (a2), W Bryan Burnette (a3), Kan Hor (a4), Joanne Chisolm (a4), Christopher Spurney (a5), Justin Godown (a1), Meng Xu (a6), James C Slaughter (a6) and Larry W Markham (a1) (a7)...

Abstract

Background

Outcome analyses in large administrative databases are ideal for rare diseases such as Becker and Duchenne muscular dystrophy. Unfortunately, Becker and Duchenne do not yet have specific International Classification of Disease-9/-10 codes. We hypothesised that an algorithm could accurately identify these patients within administrative data and improve assessment of cardiovascular morbidity.

Methods

Hospital discharges (n=13,189) for patients with muscular dystrophy classified by International Classification of Disease-9 code: 359.1 were identified from the Pediatric Health Information System database. An identification algorithm was created and then validated at three institutions. Multi-variable generalised linear mixed-effects models were used to estimate the associations of length of stay, hospitalisation cost, and 14-day readmission with age, encounter severity, and respiratory disease accounting for clustering within the hospital.

Results

The identification algorithm improved identification of patients with Becker and Duchenne from 55% (code 359.1 alone) to 77%. On bi-variate analysis, left ventricular dysfunction and arrhythmia were associated with increased cost of hospitalisation, length of stay, and mortality (p<0.001). After adjustment, Becker and Duchenne patients with left ventricular dysfunction and arrhythmia had increased length of stay with rate ratio 1.4 and 1.2 (p<0.001 and p=0.004) and increased cost of hospitalization with rate ratio 1.4 and 1.4 (both p<0.001).

Conclusions

Our algorithm accurately identifies patients with Becker and Duchenne and can be used for future analysis of administrative data. Our analysis demonstrates the significant effects of cardiovascular disease on length of stay and hospitalisation cost in patients with Becker and Duchenne. Better recognition of the contribution of cardiovascular disease during hospitalisation with earlier more intensive evaluation and therapy may help improve outcomes in this patient population.

Copyright

Corresponding author

Author for correspondence: J. H. Soslow, MD, MSCI, Assistant Professor, Pediatrics, Thomas P. Graham, Jr. Division of Pediatric Cardiology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, 2200 Children’s Way, Suite 5230, Doctors’ Office Tower, Nashville, TN 37232-9119, USA. Tel: +1-615-322-7447; Fax: +1-615-322-2210; E-mail: jonathan.h.soslow@vanderbilt.edu

Footnotes

Hide All

Cite this article: Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. (2019) Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiology in the Young29: 290–296. doi: 10.1017/S1047951118002226

Footnotes

References

Hide All
1. Dooley, J, Gordon, KE, Dodds, L, MacSween, J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila) 2010; 49: 177179.
2. Bushby, KM, Thambyayah, M, Gardner-Medwin, D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337: 10221024.
3. Moser, H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 1984; 66: 1740.
4. Hoffman, EP, Brown, RH Jr., Kunkel, LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919928.
5. Nigro, G, Comi, LI, Politano, L, Bain, RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990; 26: 271277.
6. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005; 116: 15691573.
7. Eagle, M, Baudouin, SV, Chandler, C, Giddings, DR, Bullock, R, Bushby, K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12: 926929.
8. Bach, JR, Martinez, D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care 2011; 56: 744750.
9. Punnoose, AR, Kaltman, JR, Pastor, W, McCarter, R, He, J, Spurney, CF. Cardiac disease burden and risk of mortality in hospitalized muscular dystrophy patients. Pediatr Cardiol 2016; 37: 12901296.
10. Connuck, DM, Sleeper, LA, Colan, SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008; 155: 9981005.
11. Spurney, C, Shimizu, R, Morgenroth, LP, et al. Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 2014; 50: 250256.
12. Eagle, M, Bourke, J, Bullock, R, et al. Managing Duchenne muscular dystrophy—the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 2007; 17: 470475.
13. Thayer, S, Bell, C, McDonald, CM. The direct cost of managing a rare disease: assessing medical and pharmacy costs associated with Duchenne muscular dystrophy in the United States. J Manag Care Spec Pharm 2017; 23: 633641.
14. Teoh, LJ, Geelhoed, EA, Bayley, K, Leonard, H, Laing, NG. Health care utilization and costs for children and adults with duchenne muscular dystrophy. Muscle Nerve 2016; 53: 877884.
15. Schreiber-Katz, O, Klug, C, Thiele, S, et al. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany. Orphanet J Rare Dis 2014; 9: 210.
16. Landfeldt, E, Lindgren, P, Bell, CF, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology 2014; 83: 529536.
17. Bach, JR, Tran, J, Durante, S. Cost and physician effort analysis of invasive vs. noninvasive respiratory management of Duchenne muscular dystrophy. Am J Phys Med Rehabil 2015; 94: 474482.

Keywords

Type Description Title
WORD
Supplementary materials

Soslow et al. supplementary material
Table S1

 Word (98 KB)
98 KB
WORD
Supplementary materials

Soslow et al. supplementary material
Tables S2A-C

 Word (18 KB)
18 KB
WORD
Supplementary materials

Soslow et al. supplementary material
Table S3

 Word (20 KB)
20 KB
WORD
Supplementary materials

Soslow et al. supplementary material
Table S4

 Word (15 KB)
15 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed